Addex Therapeutics Ltd American Depositary Shares
Symbol: ADXN (NASDAQ)
8.69
▲ (3.52%) 0.295
Company Description:
Addex Therapeutics Ltd is a clinical-stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment, which is the discovery, development, and commercialization of small-molecule pharmaceutical products.
Key Stats
- Today's Open: $8.988
- Today's High: $8.988
- Today's Low: $8.685
- Today's Volume: 985
- Yesterday Close: $8.39
- Yesterday High: $8.895
- Yesterday Low: $8.39
- Yesterday Volume: 1.28K
- Last Min Volume: 4
- Last Min High: $8.685
- Last Min Low: $8.685
- Last Min VWAP: $8.685
Company Profile
- Name: Addex Therapeutics Ltd American Depositary Shares
- Website: https://www.addextherapeutics.com
- Listed Date: 2020-01-29
- Location: ,
- Market Status: Active
- CIK Number: 0001574232
- SIC Code:
- SIC description:
- Market Cap: $9.16M
- Round Lot: 100
- Outstanding Shares: 1.07M
- Asset Type: ADRC
RECENT FILINGS FOR ADXN
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-06-06 | 6-K | View |
| 2025-05-15 | 20-F | View |
| 2025-05-12 | 6-K | View |
| 2025-04-30 | NT 20-F | View |
| 2025-04-30 | 6-K | View |
| 2025-04-25 | 6-K | View |
| 2025-04-17 | 6-K | View |
| 2024-11-22 | 6-K | View |
| 2024-11-12 | 6-K | View |
| 2024-09-30 | 6-K | View |
| 2024-09-19 | 6-K | View |
| 2024-08-27 | 6-K | View |
| 2024-08-14 | SC 13D/A | View |
| 2024-08-05 | SC 13D/A | View |
| 2024-07-22 | 6-K | View |
| 2024-07-15 | 6-K | View |
| 2024-07-01 | 6-K | View |
| 2024-06-06 | 6-K | View |
| 2024-06-05 | 6-K | View |
| 2024-04-29 | 6-K | View |